WRLD A.LIVE

04:003 reports

• Michael Steinberg: PSMA-Targeted Radioligand Therapy Plus SBRT Reduces Progression Risk by 62% Oncodaily
• Targeted radioactive therapy may help delay spread of recurrent prostate cancer, UCLA study suggests UCLA Health
• Lu-177 PNT2002 before SBRT extends disease control in prostate cancer AuntMinnie

03:00nothing heard

02:001 report

• Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression Nature

01:003 reports

• CityUHK research reveals modulating chromatin dynamics of H2B mutations, shedding light on novel targeted therapy of breast cancer Asia Research News |
• Single-cell analysis reveals how pancreatic cancer evades treatment News-Medical
• Metastatic Breast Cancer Patient Continues To Watch Family Grow Thanks to Clinical Trial Moffitt

00:005 reports

• New AI Model Decodes the Signals That Guide Immune Cells Into Tumors Bioengineer.org
• Tumor suppressor gene mutations trigger immune activation in early oral cancer Medical Xpress
• Trial Offers Metastatic Breast Cancer Treatment Without Chemotherapy or Radiation | Newswise Newswise
• AI Tool Reveals What Attracts Immune Cells to Tumors and What Keeps Them Away | Newswise Newswise
• New research reveals the role of exercise in fighting cancer The Independent